文献速递脑血管病认知障碍与痴呆

缺血影像表型与脑萎缩及脑血管病灶进展的关联:SMART-MR研究

Association of Ischemic Imaging Phenotype With Progression of Brain Atrophy and Cerebrovascular Lesions on MRI: The SMART-MR Study.
PubMed 文献 · Neurology · 2021-07-21

在SMART-MR研究中,根据临床和MRI将动脉疾病患者分为无症状性血管病灶、影像阴性缺血、症状性脑血管病及参照组,用线性混合模型分析12年随访中脑体积和WMH体积变化。症状性脑血管病与基线脑体积更小、WMH体积更大及新发梗死风险增加相关;无症状性血管病灶与脑萎缩斜率更陡及腔隙灶风险增加相关;影像阴性缺血与皮层梗死风险增加相关。

要点

  • 症状性脑血管病与基线脑体积更小、WMH更大及随访新发梗死风险增加相关。
  • 无症状性血管病灶与脑萎缩斜率更陡、基线WMH更大及腔隙灶风险增加相关。
  • 影像阴性缺血与随访新发皮层梗死风险增加相关。

核心结论

  • 症状性脑血管病、无症状性血管病灶或影像阴性缺血患者的脑体积丢失和脑血管病灶发展轨迹不同。

研究设计与样本

  • SMART-MR研究纳入基线无脑血管病参照组829例、症状性脑血管病206例、无症状性血管病灶157例、影像阴性缺血90例。
  • 采用线性混合模型分析基线和12年随访中脑体积和WMH体积变化,并估计随访新发梗死的相对风险,校正年龄、性别、心血管危险因素和药物。

主要发现

  • 症状性脑血管病与基线脑体积小0.35 SD(95%CI 0.24-0.47)、WMH体积大0.61 SD(95%CI 0.48-0.74)及随访新发梗死风险增加相关(RR 2.89,95%CI 2.00-4.16)。
  • 无症状性血管病灶与基线脑体积小0.15 SD(95%CI 0.01-0.88)、脑萎缩斜率陡0.02 SD(95%CI 0.01-0.03)、基线WMH体积大0.48 SD(95%CI 0.32-0.64)及腔隙灶风险增加相关(RR 2.08,95%CI 1.48-2.94)。
  • 影像阴性缺血与皮层梗死风险增加相关(RR 2.88,95%CI 2.17-3.82)。

临床怎么用

  • 对动脉疾病患者,可根据症状性脑血管病、无症状性血管病灶或影像阴性缺血的影像表型评估脑萎缩和脑血管病灶进展风险。

局限性

  • 研究结果需进一步调查验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVE: To investigate the association of silent vascular lesions, imaging negative ischemia, and symptomatic cerebrovascular disease with long-term progression of brain atrophy and cerebrovascular lesions in patients with arterial disease. METHODS: Within the Second Manifestations of Arterial Disease-Magnetic Resonance (SMART-MR) study, stroke status of participants at baseline was classified as no cerebrovascular disease (reference group, n = 829), symptomatic cerebrovascular disease (n = 206), silent vascular lesion (n = 157), and imaging-negative ischemia (n = 90) according to clinical and MRI findings. With the use of linear mixed models, changes in brain and white matter hyperintensity (WMH) volumes at baseline and during 12 years of follow-up were studied in stroke classifications. Relative risks were estimated for new infarcts during follow-up associated with stroke classifications. Analyses were adjusted for age, sex, cardiovascular risk factors, and medications. RESULTS: Symptomatic cerebrovascular disease associated with 0.35 SD (95% confidence interval [CI] 0.24-0.47) smaller brain volume and 0.61 SD (95% CI 0.48-0.74) larger WMH volume at baseline and increased risk for new infarcts during follow-up (risk ratio [RR] 2.89, 95% CI 2.00-4.16). Silent vascular lesions were associated with 0.15 SD (95% CI 0.01-0.88) smaller brain volume, 0.02 SD (95% CI 0.01-0.03) steeper brain atrophy slope, and 0.48 SD (95% CI 0.32-0.64) larger WMH volume at baseline, in addition to increased risk for lacunes (RR 2.08, 95% CI 1.48-2.94). Individuals with imaging-negative ischemia had increased risk for cortical infarcts (RR 2.88, 95% CI 2.17-3.82). DISCUSSION: Patients with symptomatic cerebrovascular disease, silent vascular lesions, or imaging-negative ischemia have a different course of brain volume loss and cerebrovascular lesion development. These findings may have implications for future stroke risk and dementia and need further investigation.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Rissanen I, Lucci C, Ghaznawi R, et al. Association of Ischemic Imaging Phenotype With Progression of Brain Atrophy and Cerebrovascular Lesions on MRI: The SMART-MR Study. Neurology. 2021. PMID: 34290128. doi:10.1212/WNL.0000000000012539

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。